- Home
- SNOA vs AEON Comparison
SNOA vs AEON Comparison
Compare SNOA & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- AEON
- Stock Information
- Founded
- SNOA 1999
- AEON N/A
- Country
- SNOA United States
- AEON United States
- Employees
- SNOA N/A
- AEON N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- SNOA Health Care
- AEON Health Care
- Exchange
- SNOA Nasdaq
- AEON Nasdaq
- Market Cap
- SNOA 7.5M
- AEON 8.0M
- IPO Year
- SNOA 2007
- AEON N/A
- Fundamental
- Price
- SNOA $4.55
- AEON $0.74
- Analyst Decision
- SNOA
- AEON Strong Buy
- Analyst Count
- SNOA 0
- AEON 1
- Target Price
- SNOA N/A
- AEON $360.00
- AVG Volume (30 Days)
- SNOA 3.9M
- AEON 88.7K
- Earning Date
- SNOA 11-06-2025
- AEON 08-12-2025
- Dividend Yield
- SNOA N/A
- AEON N/A
- EPS Growth
- SNOA N/A
- AEON N/A
- EPS
- SNOA N/A
- AEON N/A
- Revenue
- SNOA $14,912,000.00
- AEON N/A
- Revenue This Year
- SNOA $23.00
- AEON N/A
- Revenue Next Year
- SNOA $24.59
- AEON N/A
- P/E Ratio
- SNOA N/A
- AEON N/A
- Revenue Growth
- SNOA 17.43
- AEON N/A
- 52 Week Low
- SNOA $1.75
- AEON $0.38
- 52 Week High
- SNOA $6.92
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- SNOA 55.76
- AEON 49.63
- Support Level
- SNOA $4.45
- AEON $0.70
- Resistance Level
- SNOA $4.74
- AEON $0.81
- Average True Range (ATR)
- SNOA 0.27
- AEON 0.06
- MACD
- SNOA -0.07
- AEON 0.00
- Stochastic Oscillator
- SNOA 16.38
- AEON 59.93
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.